TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191 | -89.3% | 22,857 | -68.0% | 0.02% | -91.0% |
| Q2 2023 | $1,777 | +253.3% | 71,518 | +114.1% | 0.18% | +256.0% |
| Q1 2023 | $503 | -67.8% | 33,411 | -74.7% | 0.05% | -74.2% |
| Q4 2022 | $1,560 | -99.3% | 131,893 | +234.2% | 0.19% | +525.8% |
| Q3 2022 | $234,000 | +21.9% | 39,466 | -12.8% | 0.03% | +6.9% |
| Q2 2022 | $192,000 | -68.1% | 45,281 | -28.3% | 0.03% | -64.2% |
| Q1 2022 | $601,000 | +194.6% | 63,184 | +488.1% | 0.08% | +211.5% |
| Q4 2021 | $204,000 | -39.1% | 10,744 | +66.8% | 0.03% | -52.7% |
| Q4 2020 | $335,000 | -2.3% | 6,442 | -89.5% | 0.06% | +19.6% |
| Q3 2019 | $343,000 | – | 61,115 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |